沃华医药：2025年第三季度归属于上市公司股东的净利润同比增长63.33%

Core Insights - The company reported a revenue of 199,254,868.52 yuan for the third quarter of 2025, representing a year-on-year growth of 9.77% [1] - The net profit attributable to shareholders of the listed company was 19,318,599.40 yuan, showing a significant year-on-year increase of 63.33% [1] Financial Performance - Revenue for Q3 2025: 199.25 million yuan, up 9.77% year-on-year [1] - Net profit for Q3 2025: 19.32 million yuan, up 63.33% year-on-year [1]